The traditional approach is to use anatomical knowledge to inject pain relief in the area of the nerves to be blocked.
Liz is leading a move away from this approach to a more precise method which uses ultrasound guidance to visualise the nerves, allowing the local anaesthetic to be placed directly around the nerve itself.
For some nerve blocks, it is possible to block just the sensory branches of nerves, which means pets can walk better immediately after surgery while not feeling any pain.
Liz, a past president of the Association of Veterinary Anaesthetists, said: “Local analgesia is now at the forefront of our post-operative care and reliably improves the quality of a pet’s recovery and reduces the need for opioid pain relief, which can cause side effects.
“We’re using the latest techniques to deliver the nerve-blocking anaesthetics to exactly where they’re needed.
“For many of the nerve blocks, the use of ultrasound guidance allows more precise delivery and a complete blockade of the sensory nerves, which is why, here at Paragon, we’ve invested in state-of-the art ultrasound machine designed specifically for superficial and deep nerve blocks.
“This means we can provide more effective immediate post-operative analgesia for our patients and minimise the need for further pain killers.
“The nerves can be directly visualised and local anaesthetic directly placed around the nerve bundles.”
Liz is keen to highlight the advantages of the increased use of local anaesthesia in the treatment of animals. She added: “We’re hoping we’ll soon be able to publish some clinical research on the use of some of the blocking techniques used to demonstrate our clinical impression of their effectiveness in patient management.”
Everyone who takes part in the survey, which is also open to nurses, practice support staff and veterinary students, will be entered into a free prize draw for the chance to win a 1 of 3 Amazon gift vouchers (up to the value of £200).
Lizzie Erian-Round, Head Veterinary Healthcare Advisor at Pegasus (pictured right) said: "With lockdown measures easing, it is a good time to take a deeper dive into what the future looks like. And importantly, how veterinary professionals feel about it. No one has a crystal ball but those on the veterinary frontline are already getting a sense of what could lie ahead. And we believe it’s important they get to share their view of what good support and communications look like.
Our last wave of research indicated that COVID-19 could be a major catalyst for future digital innovation and have lasting consequences for the way we practice. With that in mind we’ve focussed our new survey to be more forward facing."
Pegasus's last survey found that 84% of veterinary professionals thought that the coronavirus pandemic would change the way veterinary practices operate in the future. 78% thought more owners will buy their medicines online. 71% worried about their exposure to coronavirus at their work place and 68% worried about the impact of the pandemic on their mental wellbeing.
The survey closes at 9am GMT Tuesday 30th June The results will help animal health companies better understand how to best support and communicate with the veterinary profession beyond the pandemic.
To take part in the survey, visit: https://www.surveymonkey.co.uk/r/DRWSNWT
For a copy of the results, which will be available in July, email: animal@thisispegasus.co.uk.
Running from 14th-23rd July, the interactive webinars will be delivered in 5 half-day sessions, led by UK pet food consultants, scientists, and vets.
The course includes:
Sarah Hormozi, PFMA Head of Science & Education, said: "With some of the most credible industry experts as our speakers, this is a rare opportunity for pet professionals across the UK and EU to improve and refresh their knowledge of animal nutrition, pet food legislation, marketing regulations and manufacturing methods, from the comfort of their own home or office!”
For the full programme, list of speakers, registration details and prices, visit www.pfma.org.uk/pfma-training-webinar-series.
The university says it has implemented a range of health and safety measures to meet Government guidelines and allow for the controlled return of 150 first-year undergraduate students to its Sutton Bonington campus.
Since the latest cohort joined the university at the height of the UK lockdown, the school has delivered a programme of technology-assisted Fresher’s Week and teaching activities.
However, the return of the April cohort will enable face-to-face teaching that cannot be delivered remotely, specifically essential animal handling and health and safety skills required before students can embark on the work experience element of their course.
The practical sessions will form part of a blended approach to learning, with other lectures and tutorial support continuing to be delivered remotely to reduce the number of students in teaching buildings at any one time.
Dean of the School of Veterinary Medicine and Science Professor Gary England said: “We have missed being on campus with our students tremendously during the coronavirus lockdown and we are excited to be welcoming this cohort to Sutton Bonington in July.
“The health and safety of our students and staff has remained our top priority and has been at the heart of our planning process. Colleagues from across the university have been working intensively on the intricate detail required to ensure that adequate social distancing and hygiene measures are in place to allow this first step in a return to campus.”
Among the measures which have been introduced are:
The university says the return of its vet school cohort and the re-starting of face-to face-education at University of Nottingham Ningbo China at the end of April, where 5,000 students are now back on campus, will form the blueprint for the return of the majority of students to its UK campuses when the new academic term begins on 21 September.
The new devices are an evolution of the original v-gel device launched in 2012, which is widely used in veterinary anaesthesia and resuscitation.
Dr Muhammed Nasir, inventor of v-gel and President of Docsinnovent, said: "Our original product has proven to be extremely popular globally because it makes airway management easier; quicker; more comfortable for patients; and most importantly, safer for patients and staff.
"However, since launch our R&D team have been hard at work to make the devices even better. They are now slimmed down so that there is more room in the mouth for dentistry; they seal even better; and they are single-use, improving standards of hygiene"
Chris Geddes MRCVS, Docsinnovent’s Marketing Manager, added: "Our newly-launched website www.docsinnovent.com includes plentiful information on the new products including two hour-long CPD webinars from Dr Ivan Crotaz detailing how the new devices can be utilised for optimal airway management in anaesthetised patients.”
Information on where to buy the new products can be found at www.docsinnovent.com/distributors
The company says the acquisition is a natural fit for its behavioural range and will bolster its Adaptil portfolio with a wider variety of anxiety solutions for dogs.
Abbie King, senior behaviour product manager at Ceva Animal Health, said: “We have always been fans of the ThunderShirt range and we are therefore delighted with the acquisition, which will further strengthen our extensive portfolio of behavioural products that work in synergy with one another to provide pet owners with comprehensive anxiety solutions.”
For more information, visit: www.thundershirt.com
In an internal study, Royal Canin found that Pill Assist Cat achieved over 91% pill acceptance.
Pill Assist Cat is enriched with vitamins and prebiotics to support a cat’s recovery, and each treat contains only three calories.
Elisabete Capitao, Royal Canin Veterinary Marketing Manager said: "We know that getting cats to take pills can be quite a challenge even for the most experienced pet owners! A quarter of owners leave the veterinary clinic with oral medication for their cat, but 40% find giving pills to their cat complicated. Pill Assist Cat makes giving cats medication easy and takes the stress out of pill time."
Royal Canin says Pill Assist Cat is suitable for most types of medication, from worming tablets to medication for an illness.
The re-categorisation means veterinary practices can sell the topical parasiticides to ‘walk-in clients’ without the need of a prescription.
Andrew Fullerton, veterinary surgeon and product manager at Ceva Animal Health, said: “The new NFA-VPS category for Vectra 3D spot-on solution for dogs and Vectra Felis 423mg/42.3mg spot-on solution for cats provides veterinary practices with greater flexibility to sell easy-to-use, fast and effective parasite prevention and treatment without a prescription."
For more information, contact your Ceva Animal Health account manager or email cevauk@ceva.com.
The company says a combination of unprecedented demand for the product and logistics issues, together with an issue involving the manufacturer of the active ingredient, has resulted in a delay in receiving stock into the UK.
Animalcare says it has a shipment awaiting dispatch to the UK from its European manufacturing plant as soon as licensing is completed by the VMD, Home Office and European counterparts. There is another batch in production, expected into the UK in early March.
Kai Crawshaw, Product Manager at Animalcare, said: "We are working hard with the VMD and Home Office to expedite the import licensing process and also with our manufacturer to ensure we can get as much stock as quickly as possible back into the marketplace. We sincerely apologise to any clinics that are experiencing a shortage but are glad to say that stock is on the way."
In the study, Fluorescent tagging for environmental surface cleaning surveillance in a veterinary hospital 1, researchers at Ohio State University used a fluorescent dye to tag pre-determined surfaces in a large veterinary teaching hospital.
The dye was invisible to the naked eye, but fluoresced under a blacklight (UV-A source). It could be easily removed by regular cleaning.
Surfaces were tagged and then assessed 24 hours after tag placement to determine whether they had been cleaned. Tagging and assessment took place during non-peak hours in an attempt to eliminate observer bias. The study ran for a period of 5.5 weeks between June and July 2014 and a total of 4984 surfaces were tagged and assessed.
Jason Stull, corresponding author of the paper said: "Overall, 50% of surfaces were adequately cleaned so that the tag was completely removed. Cleaning varied widely by surface/object and hospital location. Of the surfaces designated as having primarily human contact, the equipment cart and door handle to the dog walking area were most frequently cleaned (100%), whilst examination equipment including the otoscope, ophthalmoscope and swivel light handle were the least frequently cleaned (2.3%).
"Of the surfaces designated as having primarily animal contact, the ward cage interior was the most frequently cleaned (89.0%) whilst the dog run interior was the least frequently cleaned (23.1%). In terms of hospital location, the most frequently cleaned area was radiology (77.5%) and the least frequently cleaned area was the small animal treatment area (4.2%)."
The overall proportion of surfaces satisfactorily cleaned was similar to that reported in previous studies, however, the findings for some surfaces and hospital areas differed.2 This demonstrates the importance of veterinary cleaning surveillance in individual practices so that targeted interventions can be implemented.
Nicholas Jeffery, editor of JSAP said: "With health-care associated infections being a persistent problem in human and veterinary medicine, it is important that surfaces and equipment within the veterinary practice are adequately cleaned. This research demonstrates the potential use of a commercial fluorescent dye for veterinary cleaning surveillance to inform hospital cleaning practices."
The full article can be found in the February issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13090
References
The new facilities use teaching aids and models to allow students to refine their practical skills and build confidence before being let loose on real patients.
As part of the official opening, Princess Anne toured the School of Veterinary Medicine, where she met with staff and students and saw a demonstration of a new equine gut model that offers an alternative to using live animals for research into the gut microbiota of horses and how they are affected by diet, disease and medication.
Professor Chris Proudman, Head of the School of Veterinary Medicine, said: "We are honoured to welcome The Princess Royal to the Vet School today, and very grateful that Her Royal Highness has officially opened the Large Animal Clinical Skills Facilities. Preparing students for life as a vet is our number one priority; the hands-on experience they will get through the use of this facility is invaluable and enables them to give the best possible care to all animals.
"We are also very grateful to the Longhurst family, without whom these teaching resources would not have been possible – their generosity is helping us to teach the vets of the future."
Licensed for use from 6 weeks of age - and in pregnant and lactating bitches and queens - Evicto provides adulticidal, larvicidal and ovicidal flea protection, which can also help to control environmental flea infestations in areas where the pet has access. It also treats ear mites, biting lice, intestinal roundworms, sarcoptic mange in dogs, intestinal hookworms in cats and can be used to prevent heartworm disease with monthly administration.
Evicto is presented in packs of 4 pipettes which are transparent so owners can see that the full dose has been applied. The company also highlights that with Evicto pets can be bathed 2 hours after treatment without loss of efficacy.
Claire Lewis, Product Manager at Virbac said: "We are pleased to add Evicto to our award-winning range of parasite protection products.
"Evicto can also be used concurrently with Milpro, making it the perfect product partnership."
Evicto is available from the veterinary wholesalers now.
For information, speak to your Virbac Territory Manager.
The campaign will highlight things that can be done to help anxious pets, including getting professional advice from a behaviourist or trainer and using the company's products.
There's a marketing pack for practices, to help you educate owners and promote the month. It includes bunting, wall displays, posters, leaflets and gift vouchers for pet owners.
To raise awareness, Ceva will also be running a PR and advertising campaign together with a social media initiative in which owners will be encouraged to share their experience of having an anxious pet on Instagram and Facebook.
Abigail King, senior product manager at Ceva said: "It is widely known that humans suffer from anxieties, but pets do too with 82% of dogs and 89% of cats reported to be scared of something1.
"It is therefore important that we educate pet owners on the signs of stress and the help and support that they can give to their pets.
"Pet Anxiety Month will get people talking and we want people to know that there are products out there to support pets and that help is at hand to get the right advice, which is extremely important."
For further information, visit the Pet Anxiety Month website or follow the campaign on Instagram and Facebook. To request the Pet Anxiety Month marketing pack, email cevauk@ceva.com.
Reference
MSD says Lawsonia intracellularis is found on many finishing farms throughout the UK, and can affect weight gains, feed conversion ratios (FCR) and lead to increased mortality.
The new vaccine means that if piglets are vaccinated at three weeks, they will be protected against the bacteria from seven weeks.
Rubén Del Pozo Sacristán, technical manager for pigs at MSD Animal Health, said "Lawsonia intracellularis is present on most UK farms and can hamper a farm’s true potential as it spreads rapidly in faeces and on people or rodents, but symptoms can be hard to identify, as they’re often similar to many other diseases.
"Acute forms are often noticeable with symptoms such as diarrhoea or an increase in mortality, but the subclinical form, which is most common, can be hard to identify. Diarrhoea is not always present and often indicators are an increase in FCR and a reduction in weight gain leading to variation in pig performance, but this is similar to many other health issues.
"Administering an intramuscular vaccination will ensure every animal receives the correct dose, compared to other administrative routes. Porcilis Lawsonia can help reduce the clinical signs, production losses and mortality caused by Ileitis."
For more information on Porcilis Lawsonia, refer to the SPC sheet.
Designed to help veterinary practices save clients' time and improve compliance, VetsDeliver supplies Bravecto - the company's 12 week flea and tick treatment - with the wormer of the vet's choice, by post.
Before the pandemic, practices registered clients for the service online or during an appointment and clients would have to collect the first treatments from the practice.
In response to the pandemic, however, MSD has made now it possible for clients to register from home and get their first treatments sent by post.
Amanda Melvin, Marketing Manager for Companion Animals at MSD Animal Health said: "We are all in unchartered territory and we appreciate the pressure veterinary teams are under to continue to care for their clients and local pet community.
"Many businesses are having to add new services to support online facilities and home delivery, and for vets there is also now a need to reduce footfall into practice while still generating income. Making sure effective parasite control is available will help improve compliance as temperatures rise and the risks to the health of our pets increase. It's one less thing for you and your clients to worry about."
For further information, contact your MSD Animal Health account manager or go to www.msd-animal-health-hub.co.uk/vetsdeliver.
In next year's election, there are three places on Council for elected veterinary surgeons, with successful candidates serving four-year terms.
The nomination period runs until 5pm on Friday 31 January 2020. In order to stand, candidates need to complete a nomination form, submit a short biography and personal statement and supply a high resolution digital photo.
Each candidate also needs to have two nominators who need to be veterinary surgeons who are on the RCVS Register but are not current RCVS Council members.
Eleanor Ferguson, RCVS Registrar and Returning Officer said: "As always, we would encourage those who are interested in having their say in some of the key debates in the regulatory sphere, such as our under care review, our policies around the impact of Brexit and our vision for new veterinary legislation, to become a candidate.
"RCVS Council is at its best when it encompasses a broad range of perspectives, experiences and knowledge, and so we encourage people from all areas of veterinary life and all levels of experience to put themselves forward and share their expertise and insight."
Nomination forms, guidance notes and frequently asked questions for prospective RCVS Council candidates can be found at www.rcvs.org.uk/rcvscouncil20.
Prospective candidates for RCVS Council are welcome to contact the Registrar, Eleanor Ferguson (e.ferguson@rcvs.org.uk) and the RCVS CEO, Lizzie Lockett (l.lockett@rcvs.org.uk) for more information about the role of the College and/or RCVS Council.
RCVS Council will also be holding its next public meeting on Thursday 23 January 2020, prior to the closure date for Council candidate nominations. Prospective candidates are welcome to attend the Council meeting as an observer. Contact Dawn Wiggins, RCVS Council Secretary, on d.wiggins@rcvs.org.uk if you wish to attend.
The new editorial team of Ed Hall, David Williams and Aarti Kathrani says the manual has been completely rewritten and reorganised to provide a current, well-structured overview of the main gastrointestinal diseases that challenge both clinical practitioners and academics.
The Manual is divided into four sections:
Diagnostic procedures and techniques: history taking, physical examination, clinical pathology, imaging and biopsy.
Diagnostic approaches to problems: diagnostic approach to complaints/problems affecting the GI tract, pancreas and liver.
Patient management: treatments available for GI, pancreatic and liver disease, including a chapter on fluid and nutritional therapy.
Diseases of specific systems/organs: conditions of organs of the GI tract, including pathophysiology, clinical signs, diagnosis, treatment and prognosis.
Ed Hall said: "The busy small animal practitioner is likely to see a dog or cat with GI signs most days and having this Manual as a resource should give them greater insight into the conditions they are treating and hopefully make their job more satisfying."
The BSAVA Manual of Canine and Feline Gastroenterology is available in a printed edition (£90; £60 to BSAVA members) and an online edition (£75 +VAT; £50 +VAT to BSAVA members).
Inigo’s abstract entitled “Predictive value of cardiac remodelling on survival in dogs with persistent atrial standstill – the UK perspective” sought to determine the survival of dogs in the United Kingdom with persistent atrial standstill (PAS) after pacemaker implantation and the prognostic value of cardiac remodelling. The Congress Programme Committee were impressed by Inigo’s innovative presentation, praising the planning and execution of the multi-centre project.
Ditte’s presentation was entitled “Evaluation of a point-of-care dot Enzyme-Linked Immunosorbent Assay to detect antibodies against canine parvovirus, distemper virus and adenovirus before revaccination”.
Her study described the findings of a prospective non-inferiority study of a point-of-care semi-quantitative titer test performed on canine serum samples and compared to gold standard analysis. Sensitivity, specificity, positive and negative predictive values of the point-of-care titer test were determined for the gold standard titer cut-offs for canine adenovirus, canine distemper virus and canine parvovirus. Ditte was commended by the Congress Programme Committee for the quality of presentation as well as the practical and clinically applicable findings of the study.
The BSAVA Congress Clinical Abstracts, including the winners’ abstracts, are now available to view in the BSAVA Library here: https://www.bsavalibrary.com/content/book/10.22233/9781913859039.
The new Mind Matters Initiative (MMI) Kite App is the result of a collaboration with The Kite Programme. It offers a series of bespoke microlearning modules - known as 'kites' - about mental health and wellbeing.
Microlearning is a type of learning which delivers content in bite-size modules. It usually combines a mixture of interactive activities, images and videos, which can be worked through in as little as five minutes.
The first ‘Kites’ available on the app will cover subjects like breathing activities, mindfulness, time management and physical activity for mental health.
New modules will be added over the weeks and months ahead, in response to feedback from users.
Angharad Belcher, RCVS Director for Advancement of the Professions, said: “Veterinary professionals undertake vital work for animal health and welfare, but the intensity and pressure of their work can take its toll on mental health and wellbeing. Sadly, research shows that compared to the general population, veterinary professionals are more likely to experience mental health distress, including depression and anxiety.
“We recognise how hard it can be for veterinary professionals to fit wellbeing activities into their busy workdays and understand that everyone’s mental health needs are different. By collaborating with The Kite Program, we wanted to create a wellbeing platform that was accessible, flexible and had a range of activities to meet a variety of mental health and wellbeing needs. This app will be another useful tool for the professions, and we are pleased to be able to offer it free of charge.
“We are really looking forward to hearing feedback from the professions about the platform and creating more modules based on their wants and needs.”
The College highlights that users cannot input any personal information into the app and the only data it will hold is a record of active users.
To register for the app, visit: https://www.vetmindmatters.org/mmi-app.
The app will also be demoed at BEVA Congress 2021 (5th-7th September, Birmingham ICC).
The recall was initiated because a visual inspection confirmed the possibility of particulate contamination which is not acceptable for an intravenous use preparation.
The recall is for the following batches only:
108AB Expiry 12/01/2023113H Expiry 16/03/2023
Ceva Animal Health Ltd is contacting veterinary surgeons, retailers and wholesale dealers to examine inventory and quarantine products subject to the recall.
For further information, contact Peter Kyte Business Unit Manager on +44 1494 781510.
The study, titled “Development and progression of proteinuria in dogs treated with masitinib for neoplasia: 28 cases (2010 – 2019)”, also suggests that a urine protein: creatinine greater than 0.5 should prompt reassessment within one week.
For the study, the clinical records of 38 dogs referred to a single university teaching hospital between 2010 and 2019 for treatment of neoplasia with masitinib were retrospectively evaluated.
Data was collected at masitinib initiation and at various timepoints following the start of treatment.
Data gathered included the masitinib dose given and any changes to medication administration or dosing since the previous visit, presence of gross disease and the results of haematology and biochemistry profiles, urinalysis and urine cultures.
Urinalysis results were only included if they were performed at a reference laboratory.
At each timepoint, the urine was classified as non-proteinuric (UP:C ≤0.5) or proteinurinc (UP:C >0.5). Proteinuria was then categorised as likely pre-renal, post-renal, physiological renal or pathological renal.
Dogs were grouped based on the presence or absence of proteinuria at baseline. Non-proteinuric dogs were further divided, based on whether proteinuria developed following treatment during the study.
Of the 28 dogs in the study, five were being treated for epitheliotropic lymphoma, one for vulval lymphoma, one for malignant melanoma and 21 for mast cell tumours.
Twenty-two (79%) dogs were non-proteinuric and six were proteinuric at baseline.
Of the dogs that were non-proteinuric at baseline, four (18.2%) developed proteinuria within one month of treatment initiation. Median time to first detection of proteinuria was 14.5 days (range: 13 to 31).
Of the dogs with pre-treatment proteinuria (n=6), masitinib treatment was discontinued due to lack of efficacy in three dogs, and three were euthanased during treatment, two for disease progression and one for an unknown reason.
Dr Margaux Kuijlaars, corresponding author for the paper, said: “Patients developing proteinuria should be investigated to exclude non-renal causes. This should allow for more informed recommendations on the monitoring and management of proteinuria and further masitinib treatment in these patients to be made. Masitinib treatment can be considered in patients with pre-treatment proteinuria and does not inevitably cause worsening of proteinuria.
“The findings of this study add to the evidence base for the use of masitinib in treating neoplasia in small animal patients. The use of masitinib in dogs in this study was off-licence as C-KIT MCT expression was not determined, and many dogs were treated for other tumours.”
Nicola Di Girolamo, Editor of JSAP, said: “Little is known about which dogs are predisposed to becoming proteinuric following treatment with masitinib for neoplasia. Due to the small number of dogs in this study that developed proteinuria, conclusions about predisposing factors cannot be definitely drawn.
"The findings of this study add to the evidence base and demonstrate the need for larger, prospective trials including a control population and longer period of follow-up.”
The full article can be found in the August issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13305. It is open access and can be freely accessed by anyone.
Tim was the principal veterinary surgeon at Nine Mile Veterinary Group in Wokingham, Berkshire, from its opening in 1985. He grew the business from one vet and three staff to 16 vets and 60 staff, before selling to CVS in 2007.
Thereupon he became the National Veterinary Director for CVS, supporting the business as it grew from 200 to 1200 vets and supporting individual vets and practices with management advice and clinical practice.
In more recent times Tim has been working with a peripatetic surgery group.
Tim has worked at Guide Dogs before: between 1987 and 2007, he was a Centre Veterinary Advisor at the charity’s now-closed site in Wokingham.
Tim said: “Guide dogs are fantastic to work with – they are good-natured and easy to handle, and the owners always have the best interests of the dog at heart. Plus, you know you are helping more than someone’s pet, a working dog making a real difference to a person’s life. A guide dog needs to be happy and healthy to fulfil its role. It all adds up to a very different flavour of vet work.
“I am looking forward to being back, but in a more central role with more strategic responsibility. The veterinary world has changed so much, even in the last ten years, and it will be good to draw on my experiences to help Guide Dogs traverse that change.
“It’s important that we keep the healthcare of guide dogs at the top of the priorities list; the dogs have always been at the very core of the charity. It’s crucial that we have solid relationships with veterinary practices, to ensure our dogs receive the greatest care at the best value to the charity."
The company initiated the recall after identifying a potential for the sterility/stability of the product to be compromised due to a crimping problem of the aluminium cap.
The recall is for the 100 ml bottles of the following batch only:
Batch No.0C3829 Expiry Date 03/12/2022
Vetoquinol UK Ltd is contacting veterinary surgeons and veterinary wholesalers to examine inventory immediately and quarantine products subject to this recall.
For further information, contact the Customer Services Department on +44 1280 814500 Option 1 or email: UK_office@vetoquinol.com.
The report also revealed the devastating impact on overworked veterinary staff, with some left in tears by abusive owners venting their frustration at being unable to find care for their animal.
Anecdotally, the problems highlighted by ITV News are being seen elsewhere in the country, with more and more vets now starting to question whether or not the current requirement to provide out of hours care is sustainable in a world where there are more clients who increasingly expect flea treatment advice and other non emergency situations to be dealt with at 3:00am in the morning.
Various solutions have been proposed in a forum discussion on VetSurgeon.org, including the removal of the requirement to provide an OOH service, for the RCVS to give vets the confidence to say no to non emergencies, a change to the CoPC to require vets to provide emergency care within 24 hours, not 24 hours a day, a requirement for new grads to undertake OOH as part of their PDP, and/or a requirement for OOH centres to have 3 vets on duty at any one time (which could improve working conditions).
As the ITV report pointed out, the fundamental issue is one of a shortage of supply over demand, for which there is no overnight fix. However, many feel that reducing the demands of providing OOH could ease the situation considerably.
IVC says the new brand will allow better communication for equine teams within the IVC Evidensia group as well as collaboration with the wider equine world.
IVC Evidensia Equine Vets range from graduates to European Specialists, working in both dedicated equine and mixed practice, with all practices supported by the four large equine veterinary referral hospitals in the UK: Donnington Grove Veterinary Group, Fyrnwy Equine Group, Oakham Veterinary Hospital and Pool House Equine.
IVC says the brand's mission is to put the welfare of horses at the heart of everything it does, to providing outstanding continuity of care for all equine species and breeds across the network, to be at the forefront of continual professional development, supporting and facilitating the development of clinical and leadership skills across all their equine teams, and to build the leading network for equine veterinary care across Europe.
Richard Stephenson, Chair of the IVC Evidensia Equine Clinical Board, said: "Our network brings together all forms of equine work from ambulatory practice to some of leading UK equine referral centres.
“It gives support to all our staff in their careers. We facilitate clinical development from the graduate academy, through intern training, residencies and training up to European Diplomat level.
“We provide coaching and leadership, flexible roles and friendly, inclusive teams.”
For more information, visit https://www.ivcevidensia.co.uk/Equine or stand B01 at BEVA 2021 congress.